Rapport Therapeutics, Inc. · NASDAQ:RAPP
Third Rock Ventures VI, L.P. sold 276,513 Rapport Therapeutics, Inc. shares (Form 4)
Traded May 7 to May 8, 2026 · Filed May 11, 2026
From May 7 to May 8, 2026, Third Rock Ventures VI, L.P. (10% owner) sold 276,513 Rapport Therapeutics, Inc. shares at an average US$40.12 for US$11.1M under a trading plan, leaving 6,432,715 shares. Filed May 11, 2026 (Form 4).
- Sold
- 276,513 shares
- Price
- US$40.12 average (US$40.12 to US$40.31)
- Value
- US$11.1M
- Holding after
- 6,432,715 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Sale | 271,495 | US$40.12 | 6,437,733 | Direct |
| May 8, 2026 | Common Stock | Sale | 5,018 | US$40.31 | 6,432,715 | Direct |
Source
Related
- Rapport Therapeutics, Inc.
- Third Rock Ventures VI, L.P.
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Third Rock Ventures VI, L.P. · Apr 21, 2026
- Form 4 · Ignelzi Troy A. · Oct 21, 2026
- Form 4 · Ceesay Abraham · Oct 8, 2026
- Form 4 · Gault Cheryl · Oct 1, 2026
- Form 4 · Ceesay Abraham · Sep 24, 2026
- Form 4 · Ceesay Abraham · Sep 9, 2026